Scott Young | Vice President of Corporate Communications & Investor Relations |
Michael Clayman | Chief Executive Officer |
Melissa Layman | Chief Commercial Officer |
David Arkowitz | Chief Financial Officer |
Randall Stanicky | RBC Capital Markets |
Elliot Wilbur | Raymond James |
Gary Nachman | BMO Capital Markets |
Serge Belanger | Needham & Company |
Patrick Trucchio | H.C. Wainwright |
Carl Byrnes | Northland Capital |
Francois Brisebois | Oppenheimer |
Bruce Jackson | The Benchmark Company |
Good afternoon, ladies and gentlemen. And welcome to the Flexion Therapeutics Fourth Quarter and Full Year 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
We will be facilitating a question-and-answer session at the end of today's call. [Operator Instructions] I'll now turn the call over to Scott Young, Flexion's Vice President of Corporate Communications and Investor Relations.